This Company Wants to Democratize Clinical Trials With AI

A decade ago, Pablo Graiver was working as a VP at Kayak, the online airfare aggregator, when he sat down to dinner with an old friend--a heart surgeon from his home country of Argentina. The talk turned to how tech was doing more to save folks a few bucks on a flight to Rome than to save people's lives. Right now, the US has exactly 19,816 clinical trials open and ready to recruit patients--trials of promising new therapeutics to fight everything from HIV to cancer to Alzheimer's. About 18,000 of them will get stuck on the tarmac because they won't get enough people enrolled. And a third of those will never get off the ground at all, for the same reason.